{
  "compound": "CBD",
  "condition": "CHRONIC_PAIN",
  "effect_size": "N/A (safety study)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:CHRONIC_PAIN_OBSERVATIONAL_014",
  "participants": "412 chronic pain patients on concurrent CBD + benzodiazepines",
  "year": 2021,
  "notes": "Cannabinoid-Benzodiazepine Interaction in Chronic Pain: Safety Study",
  "confidence": "medium",
  "abstract": "No increased sedation vs benzodiazepine monotherapy; 42% reduced benzodiazepine dose; no respiratory depression; cognitive function stable"
}